Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 12:51:58 UTC
Update Date2021-09-26 23:07:34 UTC
HMDB IDHMDB0253954
Secondary Accession NumbersNone
Metabolite Identification
Common NameLaflunimus
DescriptionHR325 belongs to the class of organic compounds known as trifluoromethylbenzenes. These are organofluorine compounds that contain a benzene ring substituted with one or more trifluoromethyl groups. Based on a literature review a significant number of articles have been published on HR325. This compound has been identified in human blood as reported by (PMID: 31557052 ). Laflunimus is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Laflunimus is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC15H13F3N2O2
Average Molecular Weight310.276
Monoisotopic Molecular Weight310.092912156
IUPAC Name2-cyano-3-cyclopropyl-3-hydroxy-N-[3-methyl-4-(trifluoromethyl)phenyl]prop-2-enamide
Traditional Name2-cyano-3-cyclopropyl-3-hydroxy-N-[3-methyl-4-(trifluoromethyl)phenyl]prop-2-enamide
CAS Registry NumberNot Available
SMILES
CC1=C(C=CC(NC(=O)C(C#N)=C(O)C2CC2)=C1)C(F)(F)F
InChI Identifier
InChI=1S/C15H13F3N2O2/c1-8-6-10(4-5-12(8)15(16,17)18)20-14(22)11(7-19)13(21)9-2-3-9/h4-6,9,21H,2-3H2,1H3,(H,20,22)
InChI KeyGDHFOVCRYCPOTK-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as trifluoromethylbenzenes. These are organofluorine compounds that contain a benzene ring substituted with one or more trifluoromethyl groups.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassTrifluoromethylbenzenes
Direct ParentTrifluoromethylbenzenes
Alternative Parents
Substituents
  • Trifluoromethylbenzene
  • Anilide
  • N-arylamide
  • Toluene
  • Vinylogous acid
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Carboxylic acid derivative
  • Enol
  • Carbonitrile
  • Nitrile
  • Alkyl fluoride
  • Organooxygen compound
  • Organonitrogen compound
  • Organofluoride
  • Organohalogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Cyanide
  • Organic oxygen compound
  • Organic nitrogen compound
  • Carbonyl group
  • Alkyl halide
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP2.96ALOGPS
logP3.08ChemAxon
logS-4.6ALOGPS
pKa (Strongest Acidic)5.27ChemAxon
pKa (Strongest Basic)-2.6ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area73.12 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity76.63 m³·mol⁻¹ChemAxon
Polarizability28.3 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+169.26330932474
DeepCCS[M-H]-166.90530932474
DeepCCS[M-2H]-200.84130932474
DeepCCS[M+Na]+176.10830932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
LaflunimusCC1=C(C=CC(NC(=O)C(C#N)=C(O)C2CC2)=C1)C(F)(F)F2806.9Standard polar33892256
LaflunimusCC1=C(C=CC(NC(=O)C(C#N)=C(O)C2CC2)=C1)C(F)(F)F2013.9Standard non polar33892256
LaflunimusCC1=C(C=CC(NC(=O)C(C#N)=C(O)C2CC2)=C1)C(F)(F)F2155.8Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Laflunimus,2TMS,isomer #1CC1=CC(N(C(=O)C(C#N)=C(O[Si](C)(C)C)C2CC2)[Si](C)(C)C)=CC=C1C(F)(F)F2084.9Semi standard non polar33892256
Laflunimus,2TMS,isomer #1CC1=CC(N(C(=O)C(C#N)=C(O[Si](C)(C)C)C2CC2)[Si](C)(C)C)=CC=C1C(F)(F)F2052.0Standard non polar33892256
Laflunimus,2TMS,isomer #1CC1=CC(N(C(=O)C(C#N)=C(O[Si](C)(C)C)C2CC2)[Si](C)(C)C)=CC=C1C(F)(F)F2264.9Standard polar33892256
Laflunimus,2TBDMS,isomer #1CC1=CC(N(C(=O)C(C#N)=C(O[Si](C)(C)C(C)(C)C)C2CC2)[Si](C)(C)C(C)(C)C)=CC=C1C(F)(F)F2542.8Semi standard non polar33892256
Laflunimus,2TBDMS,isomer #1CC1=CC(N(C(=O)C(C#N)=C(O[Si](C)(C)C(C)(C)C)C2CC2)[Si](C)(C)C(C)(C)C)=CC=C1C(F)(F)F2429.1Standard non polar33892256
Laflunimus,2TBDMS,isomer #1CC1=CC(N(C(=O)C(C#N)=C(O[Si](C)(C)C(C)(C)C)C2CC2)[Si](C)(C)C(C)(C)C)=CC=C1C(F)(F)F2486.4Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Laflunimus GC-MS (Non-derivatized) - 70eV, Positivesplash10-014i-8591000000-98632418df42ccea88432021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Laflunimus GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Laflunimus GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Laflunimus GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Laflunimus GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Laflunimus GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Laflunimus 10V, Positive-QTOFsplash10-03di-0009000000-06c26579e7acf81f64122021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Laflunimus 20V, Positive-QTOFsplash10-00kn-9610000000-41ca477d818136d066fd2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Laflunimus 40V, Positive-QTOFsplash10-0f6x-9370000000-61e2c274a1cabfe0c19b2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Laflunimus 10V, Negative-QTOFsplash10-0a4i-0109000000-6697548fde914fa9a7312021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Laflunimus 20V, Negative-QTOFsplash10-0a4i-5914000000-0c0bf353d99efd8f4ca22021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Laflunimus 40V, Negative-QTOFsplash10-00xr-7920000000-26fc4d6a053f67b2f3e42021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID58190890
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound66583751
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]